Inventor · disambiguated record
Ozan Alkan
Also filed as: ALKAN OZAN
4 granted patents·10 pending applications·6 citations·filing 2017–2024
68Inventor score
Top patents by PatentIndex Score
14 records- 0191US10570119B2Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)MERRIMACK PHARMACEUTICALS INC·Filed 2017·Granted Feb 25, 2020·4 cites·15 claims
- 0288US11787781B2Inhibiting ataxia telangiectasia and RAD3-related protein (ATR)CELATOR PHARMACEUTICALS INC·Filed 2021·Granted Oct 17, 2023·1 cites·20 claims
- 0386US2025333396A1Inhibiting ataxia telangiectasia and rad3-related protein (atr)CELATOR PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0483US11028076B2Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)CELATOR PHARMACEUTICALS INC·Filed 2020·Granted Jun 8, 2021·1 cites·20 claims
- 0582US2023416236A1Inhibiting ataxia telangiectasia and rad3-related protein (atr)CELATOR PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0655US2024181085A1Non-viral dna vectors and uses thereof for expressing pfic therapeuticsGENERATION BIO CO·Filed 2022·Application pending·0 cites
- 0749US2021388379A1Modified closed-ended dna (cedna) comprising symmetrical modified inverted terminal repeatsGENERATION BIO CO·Filed 2019·Application pending·0 cites
- 0848US2022119840A1Closed-ended dna (cedna) and use in methods of reducing gene or nucleic acid therapy related immune responseGENERATION BIO CO·Filed 2020·Application pending·0 cites
- 0946US2022228171A1Compositions and production of nicked closed-ended dna vectorsGENERATION BIO CO·Filed 2020·Application pending·0 cites
- 1044US2021059953A1Lipid nanoparticle formulations of non-viral, capsid-free dna vectorsGENERATION BIO CO·Filed 2018·Application pending·0 cites
- 1142US12442015B2Closed-ended DNA vectors obtainable from cell-free synthesis and process for obtaining ceDNA vectorsGENERATION BIO CO·Filed 2019·Granted Oct 14, 2025·0 cites·16 claims
- 1242US2020283794A1Modified closed-ended dna (cedna)GENERATION BIO CO·Filed 2018·Application pending·0 cites
- 1342US2022042035A1Non-viral dna vectors and uses thereof for antibody and fusion protein productionGENERATION BIO CO·Filed 2019·Application pending·0 cites
- 1441US2022290186A1Gene editing using a modified closed-ended dna (cedna)GENERATION BIO CO·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ozan Alkan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →